Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
10.46B | 12.49B | 8.70B | 6.83B | 6.80B |
Gross Profit | ||||
4.35B | 1.93B | 1.74B | 2.10B | 1.82B |
EBIT | ||||
2.61B | 1.11B | 1.24B | 900.00M | 769.80M |
EBITDA | ||||
3.67B | 831.80M | 4.14B | 1.46B | 1.91B |
Net Income Common Stockholders | ||||
1.71B | -158.00M | 3.03B | 2.28B | 167.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.04B | 1.21B | 1.13B | 1.60B | 421.00M |
Total Assets | ||||
28.27B | 27.14B | 25.76B | 21.59B | 21.03B |
Total Debt | ||||
9.13B | 10.94B | 10.12B | 10.88B | 11.34B |
Net Debt | ||||
8.10B | 9.73B | 8.98B | 9.28B | 10.92B |
Total Liabilities | ||||
16.47B | 17.91B | 17.64B | 16.38B | 17.28B |
Stockholders Equity | ||||
11.05B | 8.58B | 8.08B | 5.21B | 3.75B |
Cash Flow | Free Cash Flow | |||
1.35B | -360.90M | 121.40M | 593.30M | 42.80M |
Operating Cash Flow | ||||
3.86B | 1.46B | 1.58B | 1.77B | 1.25B |
Investing Cash Flow | ||||
-2.86B | -2.96B | -744.90M | 443.70M | -1.01B |
Financing Cash Flow | ||||
-857.60M | 1.35B | -1.38B | -778.70M | -603.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $5.84B | 3.84 | 28.91% | 11.07% | 3.39% | 46.79% | |
77 Outperform | $5.58B | 2.46 | 9.47% | 2.89% | -4.45% | ― | |
72 Outperform | $23.93B | 9.82 | 21.53% | 3.35% | -9.86% | 240.30% | |
68 Neutral | $45.93B | 15.96 | 9.55% | 3.55% | -18.00% | -7.54% | |
62 Neutral | $8.60B | 12.04 | 6.29% | 4.50% | 3.04% | -9.39% | |
56 Neutral | $18.78B | 2,667.59 | 0.96% | 5.87% | 17.33% | -92.62% | |
52 Neutral | $7.10B | 4.22 | 39.65% | 7.08% | -3.14% | 563.59% |